Good MorningIt was another wild day for the market on Wednesday. The major indices began the day with gains after some early reports on Q3 earnings came in better than expected. Comments from Treasury Secretary Steven Mnuchin put a damper on sentiment. The Secretary says a stimulus deal of any form is unlikely to happen before the election. This puts the possibility of stimulus in a new light as it means waiting another month for a stimulus that may never come.
In other news, earnings from the big banks have been mostly positive if a bit mixed. Wednesday’s news includes a report from Wells Fargo that shows the company is on solid-footing if not positioned to rebound in 2021. By the end of the week of all of the U.S. largest financial institutions will have reported giving a fairly broad look at the state of the economy. Later this week reports from Alcoa, Morgan Stanley, and J.B. Hunt Transportation Services may move the market.
Featured: Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad) 
|
Consumer Discretionary | | Start-up Chinese electric vehicle (EV) maker Li Auto Inc. (NASDAQ: LI) shares have gained from the frenetic boom in the EV market. The Company recently went public at $11.50 per share in July 2020 reaching a peak of $24.48 before selling off to $14.97 to stabilize. While SPACs have been the rage dri... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Markets | |
Investors that are interested in the electric vehicle (EV) space have a lot of different companies to choose from. Many of these stocks have performed well this year and continue to benefit from bullish momentum thanks to optimism surrounding the industry and environmental concerns. As these compa... Read the Full Story |
|
Healthcare | | Sorrento Therapeutics Coming To A Boil On COVID-19 Candidates
Sorrento Therapeutics (NASDAQ:SRNE) emerged as a COVID-19 play earlier this year. The company is a clinical-stage biopharmaceutical company focused on antibody-derived treatments. It was among the first to discover useful antibodies that... Read the Full Story |
|
From Our Partners | | Hedge funds are rotating out of AI hype and into the hardware layer powering it. New research identifies three profitable U.S. infrastructure companies leading this shift.
One just posted 76% year-over-year data-center growth. Another holds a $12 billion backlog from global hyperscalers. A third is generating 59%+ gross margins on next-gen chips. | | Access the full analysis, price setups, and catalysts now |
|
Finance | | Wells Fargo Is The Lagging Stock In A Lagging Sector
Wells Fargo (NYSE:WFC) has had a rough couple of years. Scandal after scandal set the stock up for a big fall when the pandemic struck and now it is trading at the lowest levels in a decade. The upshot is the company has been working on its probl... Read the Full Story |
|
Healthcare | | Johnson & Johnson (NYSE: JNJ) reported its Q3 results before the bell yesterday and the numbers looked great and beat expectations. But shares dipped more than 2% in yesterday’s session.
Though the whisper numbers could have been a bit higher than the published estimates, I’m not su... Read the Full Story |
|
From Our Partners | | BioStem Technologies (NASDAQ: BSEM) just completed its Nasdaq debut, and hospital revenue already makes up about 87% of first-quarter sales.
The BioTissue acquisition added the Neox and Clarix portfolios and GPO relationships, while the direct sales team grew from 18 to 35 reps in a single quarter.
A peer-reviewed trial found a 53% complete wound closure rate with BioREtain allografts versus 31% for standard care, backing coverage from Zacks Small-Cap Research and H.C. Wainwright. | | Discover how BSEM is building out its regenerative medicine platform |
|
Markets | |
Sometimes a company issues positive news and its stock price inexplicably goes down. Investors that take advantage of these situations can come out ahead when the market catches up with reality.
Last week GenMark Diagnostics (NASDAQ:GNMK) provided better than expected revenue guidance and announc... Read the Full Story |
|
Industrials | |
A Golden-Age For Fastenal?
I’ve heard (read I should say) that current conditions are a “golden age” for homebuilders. Pent-up demand, low inventory, streamlined businesses, and low-interest rates are combining in a way that means sustained, healthy business for the home builder... Read the Full Story |
|
Finance | | JPMorgan Chase & Co Is A Buy After Reporting Q3 Result
After reviewing the JPMorgan Chase & Co (NYSE:JPM) calendar Q3 earnings report and looking at the chart I cannot believe this stock is still trading at such a low valuation. Trading at only 17X this year’s consensus and 12X next i... Read the Full Story |
|
Healthcare | |
Admittedly, things weren't looking good for AstraZeneca (LON:AZN) for a while there. With good reason, too; its vaccine trials were stopped dead in their tracks when some truly disastrous side effects started showing up, and that might well have knocked the company out of the COVID-19 recovery sta... Read the Full Story |
|
Consumer Discretionary | | The Upgrades Are Already Rolling In For Levi Strauss
Levi Strauss (NYSE:LEVI) reported earnings about a week ago and blew away the consensus. The company proved that established brands with a healthy eCommerce presence are well-positioned for the pandemic. The company saw its revenue fall nearly 27... Read the Full Story |
|
The Early Bird Stock Of The Day Ceridian HCM Holding Inc., together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market. The company also provides Bureau solutions for payroll and payroll-related services. It sells its solutions through direct sales force and third-party channels. The company was incorporated in 2013 and is headquartered in Minneapolis, Minnesota. | | View Today's Stock Pick |
|
